Diabetes mellitus (DM) affects more than 5% of the world population. The third disease in the structure of causes of death is DM [I.I. Dedov, T.L. Kuraeva, V.A. Peterkova, V.V. Potemkin, E.G. Starostina, N.E. Yuldashova, N.E. Suleimanova, Z.H. Lapasova, N.N. Yormukhamedova, Finucane MM, Danaei G, Ezzati M, Ahmad O, Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser DK, Jeon CY, Murray MB, Lipsky B., Berendt A., Deery H.G.,Currently, there are more than 350000 thousand officially registered patients in Uzbekistan. Various foot problems occur in every second patient with diabetes, the number of lower limb amputations in patients with diabetes in the Republic of Uzbekistan is 20-30 times higher than the number of amputations in patients without diabetes. Lethality, in case of amputation at the level of the shin, is 5-20%, at the level of the thigh 10-40% of operated patients [Askarov T.A., Hamdamov B.Z., Akhmedov R.M., Safoev B.B., Jalilova Z.O., Dovlatov S.S., Teshayev SH.J.]. Diabetic foot syndrome (DFS) is diagnosed in 8-10% of diabetic patients [DedovI.I., Udovichenko O.V., Grekova N.M., Galstyan G.R., Shestakova M.V., Vikulova O.K.,]. In 20-25% of cases in patients with SDS there are various purulent-necrotic lesions [Golbraik VA, Sitarkov SV, Bensman., Hall P.A., Levison D.A., Woods A.L., Kellock D.B., Watkins J.A., Barnes D.M., Gillett C.E., Camplejohn R., Dover R., Khamraeva F. M., Nazarova S. K., Fayzieva M. F.]. Purulent-necrotic manifestations of SDS are the most frequent cause of amputation and mortality of patients in this category of patients [Grekova N.M., Bordunovsky V.N., Ignatovich I.N., Bensman S.V., Burleva E.P., Aszmann O.C., Boulton AJ.M.,].

diabetes mellitus, osteomyelitis, osteoarthropathy, amputation.

Tsvetkov V.O., Kolovanova O.V., Ezhova L.G., Gusarova T.A. Informativeness of bacteriological examination of bone tissue in diabetic foot syndrome // Diabetes Mellitus, 2019, No. 5, P. 428-435 (SCOPUS).

Tsvetkov V.O., Kolovanova O.V., Mikayelyan L.S., Gambaryan K.U., Solovieva A.M. Osteomyelitis of diabetic foot: balance between radical surgical treatment and prolonged antibiotic therapy from the position of a surgeon // Consilium Medicum, 2020, 22(4), P. 61-65 (VAK).

Tsvetkov V.O., Kolovanova O.V., Gorshunova E.M., Kozlov J.A., Gobedgishvili V.V. Two-phase amputation among critically ill patients with gangrene of lower limbs as a way to improve treatment outcome. Cohort study // Annals of Medicine and Surgery, 2020, 60, S. 587-591 (SCOPUS).

Sudnitsyn A.S., Stupina T.A., Varsegova T.N., Stogov M.V., Kireeva E.A., Mezentsev I.N.. Pathomorphological and pathochemical characteristic of the osteomyelitis focus in patients with diabetic osteoarthropathy (Charcot foot). Diabetes mellitus. 2022;25(4):368-377. (In Russ.)

Purulent-necrotic lesions in the neuroischemic form of diabetic foot syndrome / V.A. Mitish [et al] // Surgery. Journal of N.I. Pirogov.-2014.- № 1.-C. 48-53.

Giurato L., Meloni M., Izzo V., Uccioli L. Osteomyelitis in diabetic foot: A comprehensive overview. World J Diabetes. 2017 Apr 15;8(4): 135-142

Przybylski MM, Holloway S, Vyce SD, Obando A: Diagnosing osteomyelitis in the diabetic foot: a pilot study to examine the sensitivity and specificity of Tc white blood cell-labeled single photon emission computed tomography/computed tomography. Int Wound J 2016, Jun;13(3):382-9

Nogueral T.M., Alcalá A.L., Beltrán L.S., Cabrera M.G., Cabrero J.B., Vilanova J.C. Advanced MR Imaging Techniques for Differentiation of Neuropathic Arthropathy and Osteomyelitis in the Diabetic Foot RadioGraphics Vol. 2017, 37, No. 4